Cargando…
Safety and Efficacy of HU-014 in the Treatment of Post-Stroke Upper Limb Spasticity: A Phase I Pilot Study
Botulinum toxin type A (BTX-A) is widely used for treating post-stroke upper limb spasticity. We evaluated the safety and efficacy of HU-014 in treating post-stroke upper limb spasticity. Thirteen patients were administered with HU-014. The primary outcome was safety, including adverse events, vital...
Autores principales: | Lee, Junekyung, Chun, Min Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693132/ https://www.ncbi.nlm.nih.gov/pubmed/36355980 http://dx.doi.org/10.3390/toxins14110730 |
Ejemplares similares
-
Safety and efficacy of MT10107 in post-stroke upper limb spasticity treatment: A phase I randomized controlled trial
por: Lee, Junekyung, et al.
Publicado: (2022) -
Effect of post-stroke spasticity on voluntary movement of the upper limb
por: Lackritz, Hadar, et al.
Publicado: (2021) -
Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013) -
Early AbobotulinumtoxinA (Dysport(®)) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
por: Rosales, Raymond L, et al.
Publicado: (2018) -
Randomized, placebo‐controlled trial of incobotulinumtoxina for upper‐limb post‐stroke spasticity
por: Elovic, Elie Paul, et al.
Publicado: (2015)